P. D. Ready, Epidemiology of visceral leishmaniasis, Clin Epidemiol. 3 mai, vol.6, pp.147-54, 2014.

J. Van-griensven and E. Diro, Visceral Leishmaniasis: Recent Advances in Diagnostics and 267

, Treatment Regimens. Infect Dis Clin North Am, vol.33, issue.1, pp.79-99, 2019.

, Références bibliographiques

M. Aboudourib, La leishmaniose viscérale infantile

J. Alvar, I. D. Vélez, C. Bern, M. Herrero, P. Desjeux et al., Leishmaniasis worldwide and global estimates of its incidence, den Boer, M., and WHO Leishmaniasis Control Team, vol.7, p.35671, 2012.

J. Alvar, P. Aparicio, A. Aseffa, . Den, M. Boer et al., The relationship between leishmaniasis and AIDS: the second 10 years, Clin. Microbiol. Rev, vol.21, pp.334-359, 2008.

S. Antinori, S. Calattini, E. Longhi, G. Bestetti, R. Piolini et al., Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a singlecenter, 8-year experience in Italy and review of the literature, Clin. Infect. Dis, vol.44, pp.1602-1610, 2007.

K. Aoun, F. Jeddi, F. Amri, J. Ghrab, and A. Bouratbine, Actualités épidémiologiques de la leishmaniose viscérale en Tunisie, 2009.

R. Badaro, T. C. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed et al., New perspectives on a subclinical form of visceral leishmaniasis, J. Infect. Dis, vol.154, pp.1003-1011, 1986.

A. Biglino, C. Bolla, E. Concialdi, A. Trisciuoglio, A. Romano et al., , 2010.

, Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic, J. Clin. Microbiol, vol.48, pp.131-136

M. Boelaert, K. Verdonck, J. Menten, T. Sunyoto, J. Van-griensven et al., Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease, Cochrane Database Syst Rev CD009135, 2014.

C. Bogdan, Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example, Cell. Microbiol, vol.10, pp.1221-1234, 2008.

G. Bourdoiseau, C. Hugnet, R. B. Gonçalves, F. Vézilier, E. Petit-didier et al., Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs, Vet. Immunol. Immunopathol, vol.128, pp.71-78, 2009.

N. Bourgeois, L. Lachaud, J. Reynes, I. Rouanet, A. Mahamat et al., , 2008.

, Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis, J. Acquir. Immune Defic. Syndr, vol.48, pp.13-19

N. Bourgeois, P. Bastien, J. Reynes, A. Makinson, I. Rouanet et al., Active chronic visceral leishmaniasis" in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients, HIV Med, vol.11, pp.670-673, 2010.

P. A. Buffet, É. Rosenthal, J. Gangneux, E. Lightburne, P. Couppié et al., Traitement des leishmanioses en France : proposition d'un référentiel consensuel, La Presse Médicale, vol.40, pp.173-184, 2011.

, Rapport annuel d'activité, CNRL, 2019.

I. Cruz, C. Chicharro, J. Nieto, B. Bailo, C. Cañavate et al., Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis, J. Clin. Microbiol, vol.44, pp.2343-2347, 2006.

D. D. Cunningham, On the presence of peculiar parasitic organisms in the tissue of a specimen of Delhi boil (Calcutta: Printed by the Superintendent of government printing, 1885.

M. Deniau, C. Cañavate, F. Faraut-gambarelli, M. , and P. , The biological diagnosis of leishmaniasis in HIV-infected patients, Ann Trop Med Parasitol, vol.97, issue.1, pp.115-133, 2003.

P. Desjeux, A. , and J. , Leishmania/HIV co-infections: epidemiology in Europe, Ann Trop Med Parasitol, vol.97, pp.3-15, 2003.

M. C. Duarte, D. P. Lage, V. T. Martins, M. A. Chávez-fumagalli, B. M. Roatt et al., Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis, Rev. Soc. Bras. Med. Trop, vol.49, pp.398-407, 2016.

S. El-alami, 85 années de leishmaniose au Maroc

M. L. Freire, T. Machado-de-assis, E. Oliveira, D. Moreira-de-avelar, I. C. Siqueira et al., Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis, PLoS Negl Trop Dis, vol.13, p.7484, 2019.

J. P. Gangneux, , 1999.

, Presse Med, vol.28, pp.2057-2066

L. Gradoni, Canine Leishmania vaccines: still a long way to go, Vet. Parasitol, vol.208, pp.94-100, 2015.

L. Has, Haute Autorité de santé, vol.54, 2017.

M. A. Izri, M. Deniau, C. Brière, D. Rivollet, J. C. Petithory et al., Leishmaniasis in AIDS patients: results of leukocytoconcentration, a fast biological method of diagnosis, Bull. World Health Organ, vol.74, pp.91-93, 1996.

L. Lachaud, J. Dereure, E. Chabbert, J. Reynes, J. M. Mauboussin et al., Optimized PCR using patient blood samples for diagnosis and followup of visceral Leishmaniasis, with special reference to AIDS patients, J. Clin. Microbiol, vol.38, pp.236-240, 2000.

R. Lainson and J. J. Shaw, Evolution, classification and geographical distribution, 1987.

W. B. Leishman, ON THE POSSIBILITY OF THE OCCURRENCE OF TRYPANOSOMIASIS IN INDIA, British Medical Journal, vol.1, p.1252, 1903.

N. D. Levine, J. O. Corliss, F. E. Cox, G. Deroux, J. Grain et al., A Newly Revised Classification of the Protozoa*, The Journal of Protozoology, vol.27, pp.37-58, 1980.

. Magill, Epidemiology of the leishmaniases, 1995.

C. Mary, F. Faraut, M. Drogoul, B. Xeridat, N. Schleinitz et al., Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up, Am. J. Trop. Med. Hyg, vol.75, pp.858-863, 2006.

R. Maurya, R. K. Singh, B. Kumar, P. Salotra, M. Rai et al., Evaluation of PCR for Diagnosis of Indian Kala-Azar and Assessment of Cure, J Clin Microbiol, vol.43, pp.3038-3041, 2005.

C. Meller-melloul, C. Farnarier, S. Dunan, B. Faugere, J. Franck et al., Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients, Parasite Immunol, vol.13, pp.531-536, 1991.

G. Michel, C. Pomares, B. Ferrua, M. , and P. , Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Trop, vol.119, pp.69-75, 2011.

J. Moreno, I. Vouldoukis, V. Martin, D. Mcgahie, A. Cuisinier et al., Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs, PLoS Negl Trop Dis, vol.6, 1683.

, Principaux repères sur la leishmaniose, OMS, 2019.

S. Pampiglione, P. E. Manson-bahr, M. La-placa, M. A. Borgatti, and S. Musumeci, Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar, Trans. R. Soc. Trop. Med. Hyg, vol.69, pp.60-68, 1975.

C. Papadopoulou, A. Kostoula, D. Dimitriou, A. Panagiou, C. Bobojianni et al., Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece, J. Infect, vol.50, pp.53-60, 2005.

S. Passos, L. P. Carvalho, G. Orge, S. M. Jerônimo, G. Bezerra et al., Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis, Clin. Diagn. Lab. Immunol, vol.12, pp.1164-1167, 2005.

C. Riera, R. Fisa, P. Lopez, E. Ribera, J. Carrió et al., Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up, Eur. J. Clin. Microbiol. Infect. Dis, vol.23, pp.899-904, 2004.

F. T. Silveira, R. Lainson, A. A. De-souza, M. B. Campos, L. A. Carneiro et al., Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil, Parasitol. Res, vol.106, pp.377-386, 2010.

N. Singh, M. Kumar, and R. K. Singh, Leishmaniasis: current status of available drugs and new potential drug targets, Asian Pac J Trop Med, vol.5, pp.485-497, 2012.

S. Sundar, F. Rosenkaimer, M. K. Makharia, A. K. Goyal, A. K. Mandal et al., Trial of oral miltefosine for visceral leishmaniasis, Lancet, vol.352, pp.1821-1823, 1998.

J. Alvar, I. D. Vélez, C. Bern, M. Herrero, P. Desjeux et al., Leishmaniasis worldwide and global estimates of its incidence, den Boer, M., and WHO Leishmaniasis Control Team, vol.7, p.35671, 2012.

R. Badaro, T. C. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed et al., , 1986.

, J. Infect. Dis, vol.154, pp.1003-1011

C. Bogdan, Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example, Cell. Microbiol, vol.10, pp.1221-1234, 2008.

G. Bourdoiseau, C. Hugnet, R. B. Gonçalves, F. Vézilier, E. Petit-didier et al., Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs, Vet. Immunol. Immunopathol, vol.128, pp.71-78, 2009.

P. A. Buffet, É. Rosenthal, J. Gangneux, E. Lightburne, P. Couppié et al.,

L. Lachaud, P. Marty, and J. Dedet, Traitement des leishmanioses en France : proposition d'un référentiel consensuel, La Presse Médicale, vol.40, pp.173-184, 2011.

D. D. Cunningham, On the presence of peculiar parasitic organisms in the tissue of a specimen of Delhi boil (Calcutta: Printed by the Superintendent of government printing, 1885.

P. Desjeux, A. , and J. , Leishmania/HIV co-infections: epidemiology in Europe, 2003.

, Ann Trop Med Parasitol 97 Suppl, vol.1, pp.3-15

M. C. Duarte, D. P. Lage, V. T. Martins, M. A. Chávez-fumagalli, B. M. Roatt et al., Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis, Rev. Soc. Bras. Med. Trop, vol.49, pp.398-407, 2016.

J. P. Gangneux, , 1999.

, Presse Med, vol.28, pp.2057-2066

L. Gradoni, Canine Leishmania vaccines: still a long way to go, Vet. Parasitol, vol.208, pp.94-100, 2015.

L. Jean-charles, Haute Autorité de santé, vol.54, 2017.

R. Lainson and J. J. Shaw, Evolution, classification and geographical distribution, 1987.

W. B. Leishman, ON THE POSSIBILITY OF THE OCCURRENCE OF TRYPANOSOMIASIS IN INDIA, British Medical Journal, vol.1, p.1252, 1903.

N. D. Levine, J. O. Corliss, F. E. Cox, G. Deroux, J. Grain et al., A Newly Revised Classification of the Protozoa*, The Journal of Protozoology, vol.27, pp.37-58, 1980.

. Magill, Epidemiology of the leishmaniases, 1995.

C. Mary, F. Faraut, M. Drogoul, B. Xeridat, N. Schleinitz et al., Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up, Am. J. Trop. Med. Hyg, vol.75, pp.858-863, 2006.

C. Meller-melloul, C. Farnarier, S. Dunan, B. Faugere, J. Franck et al., Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients, Parasite Immunol, vol.13, pp.531-536, 1991.

G. Michel, C. Pomares, B. Ferrua, M. , and P. , Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Trop, vol.119, pp.69-75, 2011.

J. Moreno, I. Vouldoukis, V. Martin, D. Mcgahie, A. Cuisinier et al., Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs, PLoS Negl Trop Dis, vol.6, 1683.

, Principaux repères sur la leishmaniose, OMS, 2019.

. Palatnik-de-sousa, One Health: The global challenge of epidemic and endemic leishmaniasis | Parasites & Vectors | Full Text, 2011.

S. Pampiglione, P. E. Manson-bahr, M. La-placa, M. A. Borgatti, and S. Musumeci, , 1975.

, Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar, Trans. R. Soc. Trop. Med. Hyg, vol.69, pp.60-68

C. Papadopoulou, A. Kostoula, D. Dimitriou, A. Panagiou, C. Bobojianni et al., Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece, J. Infect, vol.50, pp.53-60, 2005.

S. Passos, L. P. Carvalho, G. Orge, S. M. Jerônimo, G. Bezerra et al., Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis, Clin. Diagn. Lab. Immunol, vol.12, pp.1164-1167, 2005.

F. T. Silveira, R. Lainson, A. A. De-souza, M. B. Campos, L. A. Carneiro et al., Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil, Parasitol. Res, vol.106, pp.377-386, 2010.

B. Singh and S. Sundar, Leishmaniasis: vaccine candidates and perspectives, Vaccine, vol.30, pp.3834-3842, 2012.

N. Singh, M. Kumar, and R. K. Singh, Leishmaniasis: current status of available drugs and new potential drug targets, Asian Pac J Trop Med, vol.5, pp.485-497, 2012.

S. Sundar, F. Rosenkaimer, M. K. Makharia, A. K. Goyal, A. K. Mandal et al., Trial of oral miltefosine for visceral leishmaniasis, Lancet, vol.352, pp.1821-1823, 1998.